•
The National Health Commission, National Administration of Traditional Chinese Medicine, and National Bureau of Disease Control and Prevention have jointly published the “Reference Guidelines for Artificial Intelligence (AI) Application Scenarios in the Healthcare Industry.” These guidelines provide a comprehensive framework for the integration of AI across various sectors within the…
•
The National Health Commission (NHC) has issued a notification aimed at enhancing gerontology medical service capabilities, outlining specific work requirements. These include the construction of geriatric medicine departments, development of geriatric medical talent teams, standardization of geriatric medical diagnosis and treatment services, and enrichment of service models. Improving Geriatric Medicine…
•
The Shanghai Municipal Health Commission, along with 13 other bureaus, has issued a local adaptation of the “Key Points for Correcting Unhealthy Practices in the Field of Pharmaceutical Procurement and Sales and Medical Services in 2024,” which was originally published by the National Health Commission (NHC) and supported by 14…
•
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control and Prevention Administration have issued a notification regarding the management measures for investigator-initiated trials (ITT) in medical and health institutions, effective from October 1. ITTs within these institutions are defined as activities with individuals or…
•
The National Healthcare Security Administration (NHSA), National Health Commission, and National Medical Products Administration (NMPA) have jointly issued guidelines aimed at establishing a medical insurance payment eligibility management system for personnel at designated medical institutions. This initiative pertains to individuals at such institutions who are involved with the use of…
•
The National Health Commission, Ministry of Finance, National Administration of Traditional Chinese Medicine, and National Disease Control and Prevention Administration in China have jointly issued a notification to enhance basic public health services for the current year. The subsidy standard for per capita funding for basic public health services will…
•
The National Health Commission (NHC) has issued a notification regarding the fifth batch of pediatric drugs encouraged for research and development. The list includes 15 varieties, encompassing systemic anti-infective drugs, respiratory system medications, anti-tumor drugs, and immune modulators. This edition features 25 specifications and 8 dosage forms, and is notable…
•
China’s Ministry of Commerce, National Health Commission, and National Medical Products Administration (NMPA) have jointly released a “Notification on Carrying out Pilot Work to Expand the Opening Up of the Medical Field,” signaling a significant shift in the country’s healthcare landscape. The notification outlines measures aimed at further opening up…
•
China’s National Health Commission (NHC), in collaboration with the National Development and Reform Commission, Ministry of Finance, and 10 other ministries, has unveiled the ‘Guiding Opinions on Promoting the Construction of Healthy Villages.’ The initiative sets an ambitious vision to substantially enhance the quality and accessibility of rural healthcare services…
•
BEIJING—The National Health Commission (NHC) of China has published the “China’s Healthcare Statistical Communique 2023,” highlighting significant strides in public health outcomes and healthcare resource allocation. In 2023, the life expectancy of Chinese residents reached a historic high of 78.6 years, while both the maternal mortality rate and infant mortality…
•
The National Health Commission (NHC) has published a report titled “Recent Work on Securing Supply and Stabilizing Prices of Shortage Drugs,” outlining measures to enhance the oversight, analysis, and forecasting of drug supply and demand dynamics. The National Healthcare Security Administration (NHSA) is tasked with ongoing surveillance of drug prices…
•
The National Health Commission (NHC), National Disease Control and Prevention Administration, and National Administration of Traditional Chinese Medicine in China have jointly issued the “Key Central Township Health Center Construction Reference Standards.” The policy aims to select 1 to 2 central township health centers that will be equipped to provide…
•
The National Healthcare Security Administration (NHSA) and the National Health Commission (NHC) of China have issued a joint notification to incorporate village clinics into the Basic Medical Insurance (BMI) system, marking a significant step towards enhancing healthcare funding support for rural medical facilities. The initiative is designed to bolster the…
•
The National Health Commission (NHC) of China has released a notice detailing the results of the 2023 county hospital medical service capability evaluation, which included 2,062 hospitals and achieved a national coverage rate of 98.6%. The evaluation was conducted based on the basic and recommended standards for medical service capabilities…
•
China’s National Health Commission (NHC), in collaboration with 12 other ministries, has unveiled the ‘Health China Action-Diabetes Prevention and Treatment Action Implementation Plan (2024-2030),’ setting ambitious targets to combat diabetes. The plan aims to raise awareness of the condition among residents aged 18 and above to over 60% by 2030,…
•
China’s National Health Commission (NHC), in collaboration with two other bureaus, has unveiled the “All-Citizen Health Literacy Plan (2024-2027),” marking a strategic shift in the country’s health literacy focus from a “disease-focused” approach to a “health-focused” one. As part of the ongoing Healthy China 2035 initiative, the NHC acknowledges that…
•
The National Health Commission (NHC) has issued a notification aimed at further promoting the allocation of urban medical resources to county hospitals and grassroots medical institutions. The directive emphasizes that urban Class 3 hospitals should provide assistance to county hospitals, particularly those with underperforming metrics. The notice outlines several key…
•
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA), and a total of 14 ministries have issued the “Key Points for Correcting Unhealthy Practices in the Field of Pharmaceutical Procurement and Sales and Medical Services in 2024.” The document aims to address key personnel…
•
The National Health Commission (NHC) of China has recently announced the reinforcement of national and provincial mechanisms aimed at securing the supply of drugs that are in short supply. This initiative is designed to strengthen and refine the monitoring, early warning, and graded response system for drugs that are scarce,…
•
In a joint notification, the National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission (NHC) of China announced adjustments to the management categories of certain psychotropic drugs. Effective July 1, 2024, dextromethorphan, diphenoxylate, nalfurafine, and lorcaserin will be placed under Category II control. Concurrently, the active…
•
The National Health Commission (NHC) of China has undergone a leadership change, with Lei Haichao succeeding Ma Xiaowei as the party secretary. Ma had previously held the position of both Director and Party Secretary of the NHC. Lei Haichao arrives with extensive experience, particularly recognized for his role in driving…
•
The National Healthcare Security Administration (NHSA), National Health Commission (NHC), along with two other bureaus, have jointly issued a notification to commence unannounced inspections of medical insurance funds for the period from January 1, 2022, to December 31, 2023. The inspections will concentrate on the utilization and management of medical…
•
The National Health Commission (NHC) of China has announced that the State Council has approved the Regulations of the People’s Republic of China on the Management of Human Genetic Resources. Effective from May 1, 2024, the NHC will oversee the management of these resources, with changes to the existing filing…
•
Chinese health regulators are delving into allegations of irregular pricing practices during the national volume-based procurement (VBP) tenders for several pharmaceutical products. A joint statement issued by the National Drug Alliance Procurement Office and the Shanghai Pharmaceutical Centralized Bidding Procurement Management Office cited public complaints regarding the bidding and pricing…
•
The National Healthcare Security Administration (NHSA) of China, in conjunction with the Supreme People’s Court, the Supreme People’s Procuratorate, the Ministry of Public Security, the Ministry of Finance, and the National Health Commission, has unveiled the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to…
•
The National Healthcare Security Administration (NHSA) of China, in collaboration with the Supreme People’s Court, Supreme People’s Procuratorate, Ministry of Public Security, Ministry of Finance, and National Health Commission, has jointly issued the “2024 Special Work Plan for the Rectification of Illegal and Non-compliant Issues Related to Medical Insurance Funds.”…
•
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine, and National Disease Control and Prevention Administration have jointly issued the “Measures for the Management of National Health Emergency Teams,” a directive aimed at bolstering and standardizing the management of national health emergency teams to enhance emergency response capabilities…
•
The National Health Commission (NHC) has issued a notification with the aim of enhancing the management of midwifery services, outlining a total of six requirements to improve accessibility and service quality. The first requirement is to strengthen the planning and layout of midwifery services, with the goal of promoting provincial…
•
The National Health Commission (NHC) has issued a set of “Opinions on Strengthening Cross-departmental Law Enforcement in Medical Supervision,” addressing local health commissions, market supervision, healthcare security, traditional Chinese medicine, medical product administration, and other relevant bureaus. The document emphasizes the daily supervision of medical practice, handling of reports and…
•
The Fujian provincial health commission and medical products administration have jointly issued the “Provisional Regulations on the Management of Reception of Medical Representatives by Staff of Public Medical Institutions in Fujian Province.” These regulations mandate that pharmaceutical representatives engaging in academic promotion activities related to their products within medical institutions…
•
The National Health Commission (NHC) has issued a notification announcing the establishment of the National Authority for Containment (NAC), a new body dedicated to poliovirus management. This initiative comes in response to the significant global progress made since the World Health Organization (WHO) launched its polio eradication campaign in 1988,…
•
The National Health Commission (NHC) has granted approval for the Class A large medical equipment configuration licenses for the year 2023. This includes the installation of heavy ion proton radiation therapy systems in 21 hospitals and high-end radiation therapy equipment in 17 hospitals. In March 2023, the NHC issued the…
•
Medical institutions have reportedly been circulated with a “Notice on Issuing Work Tips for Medical Personnel Paid for Academic Lectures,” which delineates “Six Should Do’s” and “Six Prohibited Behaviors” for professional engagement in academic activities. This guidance aims to standardize the conduct of medical staff participating in lectures, ensuring compliance…
•
China’s National Cancer Center (NCC) has released the latest national cancer statistics, approved by the National Health Commission (NHC). The data, calculated in collaboration with the International Agency for Research on Cancer (IARC), aligns with the GLOBOCAN 2022 report. In 2022, China reported 4,824,700 new cancer cases, with a standard…
•
The National Health Commission (NHC) has released the “2024 National Medical Quality and Safety Improvement Goals,” along with quality control work improvement goals for various medical specialties. These goals aim to enhance management standards related to medical quality and safety. The 10 goals outlined by the NHC include improving the…
•
The National Health Commission (NHC) has announced the selection of 100 counties (cities, districts), including Beijing’s Haidian district, as national demonstration areas for the integration of medical and elderly care services. Additionally, 99 institutions, including Yuecheng Senior Living, have been designated as national demonstration institutions for this integrated care model.…
•
The National Health Commission (NHC) has released the “Novel Anti-tumor Drug Clinical Application Guidelines (2023 Edition)”, marking a significant update to the 2022 version with the inclusion of recently approved drugs and refinements to drug indications and rational medication guidance. Since the establishment of the expert committee on rational drug…
•
The National Health Commission (NHC) has issued a set of Opinions aimed at “Promoting the High Quality Development of Children’s Medical and Health Services,” outlining a comprehensive plan to enhance the children’s healthcare system across national, regional, and local levels by 2025. The initiative focuses on improving the allocation of…
•
The National Health Commission (NHC) of China, in collaboration with four other bureaus, has released the “Implementation Plan for Saving Drug Resources and Curbing Drug Waste,” an initiative aimed at streamlining measures across drug production, clinical medication, distribution, public education, waste management, and organizational enforcement. Promoting Prudent Drug Packaging and…
•
The National Health Commission (NHC) of China, in conjunction with nine other ministries, has issued comprehensive guidelines aimed at bolstering the construction of compact county-level medical care communities. The initiative seeks to enhance the efficiency of medical resource allocation and utilization, synchronize the development and governance of medical insurance, healthcare,…
•
The National Health Commission (NHC) of China has released its third list of drugs recommended for generic development, comprising 39 varieties with 75 specifications and 13 dosage forms. These cover a broad range of therapies including anti-tumor drugs, immunomodulators, anti-infective drugs, nervous system drugs, radiation diagnostic agents, and cardiovascular system…
•
The National Health Commission (NHC), in collaboration with the National Administration of Traditional Chinese Medicine (NATCM) and the Chinese Center for Disease Control and Prevention (CDC), has issued a set of Measures for Hospital Inspection Management. These measures signal the impending commencement of a new round of extensive hospital inspections,…
•
The National Medical Products Administration (NMPA), National Health Commission (NHC), and Chinese Center for Disease Control and Prevention (CDC) have jointly issued the “Medical Device Emergency Use Management Rules (trial),” which are effective immediately. These rules govern the emergency use of medical devices within a specified scope and period for…
•
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA), and other bureaus have jointly released a third list of drugs recommended for generic development. This list comprises a total of 41 drugs, which are now open for public comment for a period of 5…
•
The National Health Commission, Ministry of Science and Technology, Ministry of Education, and eight other bureaus have jointly issued the “Measures for the Review of Science and Technology Ethics (Trial)”, which came into effect on December 1, 2023. These measures are designed to ensure that scientific and technological activities are…
•
The National Medical Products Administration (NMPA) and the National Health Commission have announced the release of the first supplement to the Pharmacopoeia of the People’s Republic of China (2020 Edition), which will come into effect on March 12, 2024. This update marks a significant expansion and refinement of the country’s…
•
The National Health Commission (NHC) has released “China’s Healthcare Statistical Communique 2022,” providing a comprehensive overview of the country’s healthcare sector. The annual report reveals a growth in medical and health institutions, an increase in national health expenditure, and detailed insights into the distribution of healthcare costs. Expansion of Medical…
•
The National Health Commission has issued a notification to launch a special patient safety campaign spanning from 2023 to 2025. This initiative aims to enhance patient safety management systems in Class 2 and above hospitals, improve relevant institutional systems and working mechanisms, and timely eliminate various risks within the medical…
•
The Beijing Municipal Health Commission, in collaboration with the Beijing Municipal Medical Insurance Bureau and seven other governmental bodies, has unveiled an “Implementation Plan for Accelerating the Elimination of Cervical Cancer in Beijing (2023-2030).” This ambitious campaign aims to significantly reduce cervical cancer incidence through a series of targeted preventive…
•
The National Medical Products Administration (NMPA) and the National Health Commission (NHC) have jointly issued a notification aimed at enhancing the regulation of etomidate and modafinil. This follows last month’s announcement from the NMPA and other bureaus regarding the adjustment of the narcotics and psychotropic substances catalog, which downgraded modafinil…
•
The EU Chamber of Commerce in China has released its bi-annual “European Business in China Position Paper 2023/2024,” which compiles recommendations from over 1,700 member companies. The document aims to foster constructive dialogue between Europe and China, enhancing engagement between European firms and Chinese stakeholders for mutual benefit. The paper…
•
The National Health Commission (NHC) of China has released an updated national list of rare diseases, doubling the number of conditions to 86, including 21 cancer types. This marks the first update to China’s orphan disease schedule since the initial list of 121 conditions was introduced in 2018. Market Access…
•
The National Medical Products Administration (NMPA), Ministry of Public Security, and National Health Commission have jointly released a notification regarding the adjustment of the narcotics and psychotropic substances catalog in China. The updated catalog, which will come into effect on October 1, 2023, sees the addition of three new varieties,…
•
The National Health Commission (NHC), National Healthcare Security Administration, National Medical Products Administration (NMPA), and two additional ministries have released a third list of pediatric drugs aimed at encouraging and guiding drug developers in product development and filings. The list includes a total of 24 varieties, involving 30 specifications and…